Latest news

Insights

Top 10 Advances in Protein Engineering

Executive Summary Protein engineering is expanding the range of molecules scientists can design, optimize, and manufacture for pharmaceutical, biotechnology, industrial,...
Insights

Top 10 Supply Chain Innovations in Life Sciences

Executive Summary Life sciences supply chains are becoming more complex as pharmaceutical companies manage biologics, cell and gene therapies, temperature-sensitive...
Insights

Patient-Centric Clinical Development

Executive Summary Patient-centric clinical development places patients’ needs, experiences, and perspectives at the center of clinical research decisions. Rather than...
Clinical

Vanda Puts Social Anxiety Program on Hold After Asset Fails Phase 3 Study

Vanda Pharmaceuticals has suspended development of its experimental social anxiety treatment after a Phase 3 study failed to achieve...
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies...
Insights

Top 10 AI Investments Delivering the Highest ROI in Pharma

Executive Summary Artificial intelligence (AI) is becoming a strategic investment...
Insights

Top 10 Drivers Behind Site-less Clinical Trials

Executive Summary Clinical trials are moving beyond the traditional model in which participants repeatedly visit research sites for assessments, monitoring,...
Insights

Multi-Omics and the Next Generation of Drug Discovery

Executive Summary Drug discovery is becoming increasingly dependent on understanding the biological systems that drive disease. Genomics has helped researchers...
Insights

How Foundation Models Are Transforming Drug Discovery

Executive Summary Drug discovery is increasingly becoming a computational problem as pharmaceutical companies generate enormous amounts of biological, chemical, genomic,...
Clinical

BioNTech’s mRNA cancer vaccine fails phase 3 test

A phase 2/3 clinical trial of BioNTech’s mRNA cancer...
Clinical

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

Bristol Myers Squibb (BMS) has announced positive Phase 3...
Research & Development

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Argenx has stopped a Phase 3 study testing its marketed therapy Vyvgart Hytrulo in Sjögren’s disease after an interim...
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to $100 million in upfront and short-term milestone payments to secure...
Insights

Top 10 AI Trends Reshaping Precision Medicine

Executive Summary Precision medicine is moving from a largely genomics-driven model toward a broader approach that combines molecular, clinical, imaging,...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to...
Editorial Team -
Commercial

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion to Add Leukemia Drug TERN-701

Merck has agreed to acquire Terns Pharmaceuticals in an...
Commercial

Seyltx Secures Option to License GluN2B Antagonists from NeurOp

Seyltx, a clinical-stage biotherapeutics company based in Cambridge, Massachusetts,...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Editorial Team -
Insights

Top 10 Supply Chain Innovations in Life Sciences

Executive Summary Life sciences supply chains are becoming more complex...
Insights

Patient-Centric Clinical Development

Executive Summary Patient-centric clinical development places patients’ needs, experiences, and...
Clinical

Vanda Puts Social Anxiety Program on Hold After Asset Fails Phase 3 Study

Vanda Pharmaceuticals has suspended development of its experimental social...
Clinical

Tortugas Neuroscience Reports Positive Phase 2b Results for Schizophrenia Drug

Tortugas Neuroscience has reported positive Phase 2b trial results...

Research & Development

Market Access

Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Advances in Protein Engineering

Executive Summary Protein engineering is expanding the range of molecules...
Editorial Team -
Insights

Patient-Centric Clinical Development

Executive Summary Patient-centric clinical development places patients’ needs, experiences, and...
Editorial Team -